Table 2.
Procedural details.
| Periprocedural Medications | Aspirin | N = 123 |
| 100 (81.3%) | ||
| Cilostazol | 2 (1.6%) | |
| Heparin | 69 (56.1%) | |
| Clopidogrel | 11 (8.9%) | |
| Ticagrelor | 85 (69.1%) | |
| Prasugrel | 6 (4.9%) | |
| GP IIb/IIIa | 38 (30.9%) | |
| Cangrelor | 11 (8.9%) | |
|
| ||
| Procedural characteristics | Access site for PCI | |
| Femoral | 58 (47.2%) | |
| Radial | 65 (52.8%) | |
| Intracoronary imaging | ||
| None | 100 (81.3%) | |
| Intravascular ultrasound (IVUS) | 9 (7.3%) | |
| Optical coherence tomography (OCT) | 14 (11.4%) | |
| Contrast volume (mL, IQR) | 122.5 (100, 167.5) | |
| Radiation time (min, IQR) | 11.7 (7.5, 19.5) | |
| Door-to-balloon time (min, IQR) | 54 (32–75) | |
| Q wave on presentation | 54 (43.9%) | |
| Resolving ST elevation within 24 hours in STEMI patients | 59 (66.3%) | |
|
| ||
| Culprit vessel | Left anterior descending artery (LAD) | 39 (31.7%) |
| Right coronary artery (RCA) | 56 (45.5%) | |
| Left circumflex artery (LCx) | 11 (8.9%) | |
| Vein graft | 11 (8.9%) | |
| Left main (LM) | 1 (0.8%) | |
| Obtuse marginal artery (OM) | 3 (2.4%) | |
| Others | 3 (2.4%) | |
|
| ||
| Dominance | Left dominance | 8 (6.5%) |
| Right dominance | 108 (87.8%) | |
| Codominance | 7 (5.7%) | |
|
| ||
| TIMI flow (baseline) | 0 | 93 (75.6%) |
| 1 | 14 (11.4%) | |
| 2 | 11 (8.9%) | |
| 3 | 5 (4.1%) | |
|
| ||
| TIMI flow (final) | 0 | 3 (2.4%) |
| 1 | 2 (1.6%) | |
| 2 | 7 (5.7%) | |
| 3 | 111 (90.2%) | |
|
| ||
| Stenosis degree (before) | ≤95% | 18 (14.6%) |
| ≥99% | 105 (85.3%) | |
|
| ||
| Stenosis degree (after) | 0% | 86 (69.9%) |
| >0% | 37 (30%) | |